Business
Press Release Jul 27 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 27, 2023, titled "Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 27, 2023, titled \"Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial\". View Attachment","length":380,"tagName":"div"}]